Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONEN
  Dieser Datensatz wurde verworfen!FreigabegeschichteDetailsÜbersicht

Verworfen

Zeitschriftenartikel

Structure of a ligand−binding intermediate in wild−type carbonmonoxy myoglobin

MPG-Autoren
/persons/resource/persons95189

Schlichting,  Ilme
Department of Biomolecular Mechanisms, Max Planck Institute for Medical Research, Max Planck Society;

Externe Ressourcen

(Kein Zugriff möglich)

(Kein Zugriff möglich)

Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte in PuRe verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Chu, K., Vojtchovsky, J., McMahon, B. H., Sweet, R. M., Berendzen, J., & Schlichting, I. (2000). Structure of a ligand−binding intermediate in wild−type carbonmonoxy myoglobin. Nature, 403, 921-923. doi:10.1038/35002641.


Zusammenfassung
Small molecules such as NO, O2, CO or H2 are important biological ligands that bind to metalloproteins to function crucially in processes such as signal transduction, respiration and catalysis. A key issue for understanding the regulation of reaction mechanisms in these systems is whether ligands gain access to the binding sites through specific channels and docking sites, or by random diffusion through the protein matrix. A model system for studying this issue is myoglobin, a simple haem protein. Myoglobin has been studied extensively by spectroscopy, crystallography, computation and theory. It serves as an aid to oxygen diffusion but also binds carbon monoxide, a byproduct of endogenous haem catabolism. Molecular dynamics simulations, random mutagenesis and flash photolysis studies indicate that ligand migration occurs through a limited number of pathways involving docking sites. Here we report the 1.4 ? resolution crystal structure of a ligand−binding intermediate in carbonmonoxy myoglobin that may have far−reaching implications for understanding the dynamics of ligand binding and catalysis